| Literature DB >> 25517616 |
Liufu Deng1, Hua Liang1, Meng Xu2, Xuanming Yang2, Byron Burnette1, Ainhoa Arina1, Xiao-Dong Li3, Helena Mauceri1, Michael Beckett1, Thomas Darga1, Xiaona Huang4, Thomas F Gajewski2, Zhijian J Chen5, Yang-Xin Fu6, Ralph R Weichselbaum7.
Abstract
Ionizing radiation-mediated tumor regression depends on type I interferon (IFN) and the adaptive immune response, but several pathways control I IFN induction. Here, we demonstrate that adaptor protein STING, but not MyD88, is required for type I IFN-dependent antitumor effects of radiation. In dendritic cells (DCs), STING was required for IFN-? induction in response to irradiated-tumor cells. The cytosolic DNA sensor cyclic GMP-AMP (cGAMP) synthase (cGAS) mediated sensing of irradiated-tumor cells in DCs. Moreover, STING was essential for radiation-induced adaptive immune responses, which relied on type I IFN signaling on DCs. Exogenous IFN-? treatment rescued the cross-priming by cGAS or STING-deficient DCs. Accordingly, activation of STING by a second messenger cGAMP administration enhanced antitumor immunity induced by radiation. Thus radiation-mediated antitumor immunity in immunogenic tumors requires a functional cytosolic DNA-sensing pathway and suggests that cGAMP treatment might provide a new strategy to improve radiotherapy.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25517616 PMCID: PMC5155593 DOI: 10.1016/j.immuni.2014.10.019
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745